Up a level |
Kashiwagi, Atsunori, Shestakova, Marina V, Ito, Yuichiro, Noguchi, Masahiro, Wilpshaar, Wim, Yoshida, Satoshi and Wilding, John PH ORCID: 0000-0003-2839-8404
(2019)
Safety of Ipragliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Phase II/III/IV Clinical Trials.
DIABETES THERAPY, 10 (6).
pp. 2201-2217.
Shestakova, Marina V, Wilding, John PH ORCID: 0000-0003-2839-8404, Wilpshaar, Wim, Tretter, Reiner, Orlova, Valeria L and Verbovoy, Andrey F
(2018)
A phase 3 randomized placebo-controlled trial to assess the efficacy and safety of ipragliflozin as an add-on therapy to metformin in Russian patients with inadequately controlled type 2 diabetes mellitus.
DIABETES RESEARCH AND CLINICAL PRACTICE, 146.
pp. 240-250.